SecBot SecBot
144 ·Filed Nov 5, 2026

OCUL

OCULAR THERAPEUTIX, INC
NEUTRAL
Impact 3/10
Horizondays Processed11d 8h ago SEC0001950047-26-010732
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing indicates an officer intends to sell a modest number of shares. Monitor for actual sale execution on Form 4; the amount is small relative to typical market cap and likely routine post-vesting diversification.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$6.60
T+0 close · Nov 5, 2026 · via day close
Latest settled
−5.84%
T+5 · $6.21 · next T+20 in 20d
Vs SPY
−8.43%
α at T+5
Latest observation
−7.27%
T+6 · FF3 residual α
  1. T+0 · Nov 6 $6.60entry
  2. T+1 · 8d ago +3.87%α +1.50% · $6.85
  3. T+5 · 4d ago −5.84%α −8.43% · $6.21
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Namrata Saroj, an officer of Ocular Therapeutix, filed a Form 144 notice of intent to sell 35,370 shares of common stock, with an approximate market value of $231,836. The shares were acquired through restricted stock vesting under a registered plan on November 4, 2026. The filing signals a planned sale but does not confirm execution.

Key Facts

  • Insider Namrata Saroj (officer) filed Form 144 to sell 35,370 shares
  • Approximate sale value: $231,836
  • Shares acquired via restricted stock vesting under a registered plan on 11/04/2026
  • Proposed sale date: 11/05/2026
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services

Financial Impact

35,370 shares, approximately $231,836 based on filing estimate

dilution

Risk Factors

  • Form 144 is an intent to sell; the sale may not occur
  • No context on insider's total holdings or prior selling patterns provided

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010732
Document: 0001950047-26-010732-index.html0001950047-26-010732
Document: 0001950047-26-010732.txt0001950047-26-010732

Track record

20 reports on OCUL

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +24.88% at T+20 after the Aug 3, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 10, 20266d ago 3 Neutral 2/10 Entry $6.66 Now $6.01 −9.76% settles Nov 18
  2. Nov 9, 20267d ago 8-K Neutral 2/10 Entry $6.85 to $6.01 Now $6.01 −12.26% ▼ −12.26% −10.57% vs SPY
  3. Nov 9, 20267d ago Press Release Bearish 5/10 Entry $6.85 to $6.01 Now $6.01 +12.26% ▲ +12.26% +10.57% vs SPY
  4. Nov 5, 202611d ago 144 Neutral 3/10 Viewing Entry $6.60 to $6.21 Now $6.01 −8.87% ▼ −5.84% −8.43% vs SPY
  5. Oct 16, 20264w ago 8-K Neutral 2/10 Entry $6.29 to $6.47 Now $6.01 −4.45% ▲ +2.86% +3.01% vs SPY
  6. Oct 8, 20265w ago 144 Neutral 2/10 Entry $7.54 to $6.87 Now $6.01 −20.29% ▼ −8.89% −6.92% vs SPY
  7. Sep 2, 202610w ago Insider Cluster Neutral 4/10 Entry $10.64 to $10.49 Now $6.01 −43.52% ▼ −1.41% −0.26% vs SPY
  8. Aug 26, 202611w ago Insider Cluster Neutral 3/10 Entry $10.82 to $10.64 Now $6.01 −44.45% ▼ −1.66% −1.93% vs SPY
  9. Aug 3, 202615w ago 8-K Bullish 7/10 Entry $8.40 to $9.24 Now $6.01 −28.45% ▲ +10.00% +7.97% vs SPY
  10. Jun 17, 202621w ago Press Release Bullish 6/10 Entry $9.64 to $9.85 Now $6.01 −37.66% ▲ +2.18% +3.22% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 8h 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026